When COVID Goes Undetected

A. Menon, M. Bachan, Z. Khan
{"title":"When COVID Goes Undetected","authors":"A. Menon, M. Bachan, Z. Khan","doi":"10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4102","DOIUrl":null,"url":null,"abstract":"Introduction: COVID-19 was declared a global pandemic by the WHO in March 2020. The gold standard for diagnosis relies heavily on clinical suspicion along with PCR based assays of respiratory swabs. This nucleic acid study is highly sensitive and specific, however, there are faults, especially during the incubation period, during which the virus is hard to detect. Here we present a case of a patient, presenting with signs and symptoms of pneumonia, with serial negative viral swabs spaced out over time, who was ultimately diagnosed with COVID-19 infection via more invasive means. Case: A 49-year-old female with no significant past medical history presented to the emergency department with cough and shortness of breath for 2 days which developed when she returned to New York from Florida. Her personal history was significant for her occupation as an ER nurse and a history of vaping for 5-6 years.After arrival to the emergency department, the patient was febrile to 103.3 F, tachycardic, and hypoxic, saturating 89% on room air. Her laboratory work was significant for a mildly elevated D-dimer level, elevated CRP (11.23), normal procalcitonin level, and two negative COVID-19 swabs over 2 days. Her initial chest X ray showed multifocal pneumonia and a CT chest showed ground glass opacities amid dense consolidation. The patient was empirically treated for community-acquired bacterial pneumonia with antibiotics. The patient's respiratory and hemodynamic status started to decline, despite treatment. Ultimately, the patient required further investigation - a bronchoalveolar lavage was ultimately found to be positive for the COVID-19 virus, and the patient was immediately started on Remdesivir. Discussion: In this day and age, countries are increasingly utilizing the COVID-19 reverse-transcriptase PCR and are pushing for widespread testing for case detection, but how sensitive and specific is this test, really? Serial testing with swabs performed at intervals should be the answer as the viral load of the COVID RNA steadily rises and peaks over 0-9 days after onset of symptoms. However, this may not be the case in a majority of patients and more invasive testing using bronchoscopy and bronchoalveolar lavage may be the only way to truly diagnose COVID-19 pneumonia. The delay in confirmation, however, could prove to be truly fatal, subjecting patients to painful measures like intubation. This case brings to light the realization that nasopharyngeal/oropharyngeal swabs may not be sufficient to detect the virus with full certainty.","PeriodicalId":23169,"journal":{"name":"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: COVID-19 was declared a global pandemic by the WHO in March 2020. The gold standard for diagnosis relies heavily on clinical suspicion along with PCR based assays of respiratory swabs. This nucleic acid study is highly sensitive and specific, however, there are faults, especially during the incubation period, during which the virus is hard to detect. Here we present a case of a patient, presenting with signs and symptoms of pneumonia, with serial negative viral swabs spaced out over time, who was ultimately diagnosed with COVID-19 infection via more invasive means. Case: A 49-year-old female with no significant past medical history presented to the emergency department with cough and shortness of breath for 2 days which developed when she returned to New York from Florida. Her personal history was significant for her occupation as an ER nurse and a history of vaping for 5-6 years.After arrival to the emergency department, the patient was febrile to 103.3 F, tachycardic, and hypoxic, saturating 89% on room air. Her laboratory work was significant for a mildly elevated D-dimer level, elevated CRP (11.23), normal procalcitonin level, and two negative COVID-19 swabs over 2 days. Her initial chest X ray showed multifocal pneumonia and a CT chest showed ground glass opacities amid dense consolidation. The patient was empirically treated for community-acquired bacterial pneumonia with antibiotics. The patient's respiratory and hemodynamic status started to decline, despite treatment. Ultimately, the patient required further investigation - a bronchoalveolar lavage was ultimately found to be positive for the COVID-19 virus, and the patient was immediately started on Remdesivir. Discussion: In this day and age, countries are increasingly utilizing the COVID-19 reverse-transcriptase PCR and are pushing for widespread testing for case detection, but how sensitive and specific is this test, really? Serial testing with swabs performed at intervals should be the answer as the viral load of the COVID RNA steadily rises and peaks over 0-9 days after onset of symptoms. However, this may not be the case in a majority of patients and more invasive testing using bronchoscopy and bronchoalveolar lavage may be the only way to truly diagnose COVID-19 pneumonia. The delay in confirmation, however, could prove to be truly fatal, subjecting patients to painful measures like intubation. This case brings to light the realization that nasopharyngeal/oropharyngeal swabs may not be sufficient to detect the virus with full certainty.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
当COVID未被发现时
2020年3月,世卫组织宣布新冠肺炎为全球大流行。诊断的金标准在很大程度上依赖于临床怀疑以及基于PCR的呼吸道拭子检测。这种核酸研究具有高度的敏感性和特异性,但也存在缺陷,特别是在潜伏期,在此期间很难检测到病毒。在这里,我们提出了一例患者,表现出肺炎的体征和症状,随着时间的推移,病毒拭子连续阴性,最终通过更具侵入性的手段被诊断为COVID-19感染。病例:一名49岁女性,无明显既往病史,因从佛罗里达返回纽约后出现的咳嗽和呼吸短促2天就诊于急诊科。她的个人历史对她作为急诊室护士的职业和5-6年的电子烟史很重要。到达急诊科后,患者发热至103.3华氏度,心动过速,缺氧,室内空气饱和89%。她的实验室工作对轻度升高的d -二聚体水平、升高的CRP(11.23)、正常的降钙素原水平和2天内两次阴性的COVID-19拭子具有重要意义。她最初的胸部X光片显示多灶性肺炎,CT胸部显示密集实变中有磨砂玻璃影。对社区获得性细菌性肺炎给予经验性抗生素治疗。患者的呼吸和血液动力学状态开始下降,尽管治疗。最终,患者需要进一步调查——支气管肺泡灌洗最终发现COVID-19病毒呈阳性,患者立即开始使用瑞德西韦。讨论:在这个时代,各国越来越多地使用COVID-19逆转录酶PCR,并正在推动广泛的病例检测,但这种检测的灵敏度和特异性到底有多高?随着新冠病毒RNA的病毒载量稳步上升,并在症状出现后0-9天内达到峰值,每隔一段时间用拭子进行连续检测应该是答案。然而,大多数患者的情况可能并非如此,使用支气管镜检查和支气管肺泡灌洗进行更具侵入性的检查可能是真正诊断COVID-19肺炎的唯一方法。然而,确诊的延迟可能会被证明是真正致命的,使患者不得不采取插管等痛苦的措施。本病例使人们认识到,鼻咽/口咽拭子可能不足以完全确定地检测病毒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The global race to vaccinate Covid-19 vaccine production and tariffs on vaccine inputs Indicative list of trade-related bottlenecks and trade-facilitating measures on critical products to combat covid-19 Joint Indicative List of Critical COVID-19 Vaccine Inputs for Consultation Improving trade data for products essential to fight covid-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1